Login
SERA PROGNOSTICS, INC. logo

SERA PROGNOSTICS, INC.

Compare classes
sera.com

What Do They Do?

Develops and commercializes blood-based biomarker tests and predictive analytics products and services for pregnant women, their physicians, and health care payers.

How Do They Make Money?

Sera earns revenue from PreTRM tests, seeking payment through health systems, physician networks and insurers; it counts a test sale when results are delivered.

FY2025 revenue

Who Are Their Customers?

Sera targets health care providers, insurers and consumers for PreTRM, seeking reimbursement through integrated systems, physician networks and major insurers. Its filing also describes direct patient or consumer payment as a possible model for other products or market segments.

Do Revenues Turn Into Profits?

No. It lost $31.9M in FY2025.

Operating income, FY2025
−45067% of revenue
▲ 0% (Loss) vs FY2024 (−$36.6M, −47578%)
Net income, FY2025
−39417% of revenue
▲ +3% (Loss) vs FY2024 (−$32.9M, −42725%)
Free cash flow, FY2025
−32530% of revenue
▼ −85% (Loss) vs FY2024 (−$14.2M, −18500%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +163%
vs $16K in Q3 FY2025
Net income
▼ −3% (Loss)
vs −$7.8M in Q3 FY2025
  • Aug 19, 2026 A new CFO was appointed; the current CFO will move to an advisory role Scott Gleason is scheduled to become CFO on August 31, 2026; Austin Aerts will move to an advisory role focused on strategic initiatives and continuity.

Flat. Revenue was $81K in FY2025, about the same as the $82K of FY2021.

Broader product scope The older report centered on discovering and commercializing biomarker tests; the latest report also includes predictive analytic products and services in its business description.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support